XML 91 R79.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 8 - Collaborative Agreements (Details Textual) - USD ($)
12 Months Ended 133 Months Ended 139 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2015
Jun. 30, 2016
University of Toronto [Member] | Minimum [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $ 0.26   $ 0.26  
University of Toronto [Member] | Maximum [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price 1   $ 1  
University of Toronto [Member] | Employee Stock Option [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period     10 years  
University of Toronto [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures     25,000  
Professor [Member] | Minimum [Member] | Employee Stock Option [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period     10 years 10 years
Professor [Member] | Minimum [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price 0.26   $ 0.26  
Professor [Member] | Maximum [Member] | Employee Stock Option [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period     13 years 13 years
Professor [Member] | Maximum [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price 1   $ 1 $ 1
Professor [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures     483,299 275,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $ 1   $ 1  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares 62,500   62,500 125,000
Research and Development Expense, Sponsored Research $ 170,575 $ 67,270